 |
|
The Challenge of Designing Stroke Trials That Change Practice: MCID vs. Sample Size and Pragmatism
Mayank Goyal, Rosalie McDonough, Marc Fisher, Johanna Ospel
J Stroke. 2022;24(1):49-56. Published online 2022 Jan 31 DOI: https://doi.org/10.5853/jos.2021.02740
|
|
Citations to this article as recorded by
 Clinical trials in stroke in 2022: new answers and questions
Mayank Goyal, Nishita Singh, Johanna Ospel
The Lancet Neurology.2023; 22(1): 9. CrossRef Minimal Clinically Important Difference (MCID) in Patient-Reported Outcome Measures for Neurological Conditions: Review of Concept and Methods
Biswamohan Mishra, Pachipala Sudheer, Ayush Agarwal, M. Vasantha Padma Srivastava, Nilima, Venugopalan Y. Vishnu
Annals of Indian Academy of Neurology.2023; 26(4): 334. CrossRef Clinically important effect sizes for clinical trials using infarct growth reduction as the primary outcome: a systematic review
Nien-chen Liao, Mersedeh Bahr Hosseini, Jeffrey L Saver
Journal of NeuroInterventional Surgery.2023; : jnis-2023-020850. CrossRef
|